Etanercept plus sulfasalazine: added value in rheumatoid arthritis?

Etanercept plus sulfasalazine: added value in rheumatoid arthritis?

Detalles Bibliográficos
Main Authors:	Fisher, B, Taylor, P
Formato:	Journal article
Idioma:	English
Publicado:	2007

Títulos similares

Sulfasalazine plus Chloroquine-Induced Mood Disorder in a Patient with Rheumatoid Arthritis
por: Gulcan Gulec, et al.
Publicado: (2009-03-01)

Etanercept for the treatment of rheumatoid arthritis.
por: Blumenauer, B, et al.
Publicado: (2003)

Etanercept for the treatment of rheumatoid arthritis
por: Blumenauer, B, et al.
Publicado: (2004)

Etanercept for the treatment of rheumatoid arthritis.
por: Lethaby, A, et al.
Publicado: (2013)

Quality of life of patients with rheumatoid arthritis receiving etanercept
por: V N Amirdzanova, et al.
Publicado: (2009-08-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
por: H Mihels
Publicado: (2004-08-01)

The role of etanercept in the treatment of patients with severe rheumatoid arthritis
por: N. V. Chichasova
Publicado: (2013-12-01)

Comparative Effects of Combination Therapies; Methotrexate with Leflunomide & Sulfasalazine in the Treatment of Rheumatoid Arthritis
por: Qurrat-ul-Ain Bukhari, et al.
Publicado: (2017-06-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
por: Olivera Boskovic, et al.
Publicado: (2020-01-01)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez Rosalía, et al.
Publicado: (2011-11-01)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
por: Jian Cao, et al.
Publicado: (2019-05-01)

Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis
por: G. Valesini, et al.
Publicado: (2011-09-01)

Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis
por: B. G. Issayeva, et al.
Publicado: (2024-10-01)

Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
por: Fisher, B, et al.
Publicado: (2016)

EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
por: T.M. Bzarova, et al.
Publicado: (2011-03-01)

EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
por: T.M. Bzarova, et al.
Publicado: (2011-01-01)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
por: Andrés F. Echeverri, et al.
Publicado: (2015-01-01)

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis
por: Nizar A. Jassim
Publicado: (2015-04-01)

The effect of 677C>T and 1298A>C MTHFR polymorphisms on sulfasalazine treatment outcome in rheumatoid arthritis
por: A. Pawlik, et al.
Publicado: (2009-07-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
por: Jobanputra, P, et al.
Publicado: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
por: Jobanputra, P, et al.
Publicado: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
por: P. Jobanputra, et al.
Publicado: (2002-01-01)

Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
por: Helen Defty, et al.
Publicado: (2013-01-01)

Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
por: Maria N. Chamurlieva, et al.
Publicado: (2021-10-01)

Etanercept in Rheumatoid Arthritis: Long Term Anti-Inflammatory Efficacy in Clinical Practice
por: E. Cacace, et al.
Publicado: (2006-09-01)

Epidemiological and Clinical Factors Affecting the Response to Etanercept Among Patients with Rheumatoid Arthritis
por: Samer Imad Mohammed, et al.
Publicado: (2022-06-01)

Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Yu Wang, et al.
Publicado: (2011-01-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
por: Anna Olegovna Pchelintseva, et al.
Publicado: (2014-02-01)

Live macrophages loaded with Fe3O4 and sulfasalazine for ferroptosis and photothermal therapy of rheumatoid arthritis
por: Li Ruan, et al.
Publicado: (2024-02-01)

Why uncritical adherence to recommendations of sulfasalazine leaflet information can lead to medical error in rheumatoid arthritis?
por: Y V Muravyov
Publicado: (2003-04-01)

Influence of therapy with methotrexate, sulfasalazine and glucocorticoids on disease activity and erosions progression in patients with early rheumatoid arthritis
por: G Togizbaev, et al.
Publicado: (2007-10-01)

Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
por: E E Gubar', et al.
Publicado: (2008-05-01)

Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment
por: Shinya Hayashi, et al.
Publicado: (2022-10-01)

Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report
por: Tuite Helen, et al.
Publicado: (2010-11-01)

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
por: Al-Ani N, et al.
Publicado: (2021-04-01)

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
por: E H Vogelzang, et al.
Publicado: (2018-01-01)

Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
por: Nuria Carballo, et al.
Publicado: (2022-10-01)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Anna Felis-Giemza, et al.
Publicado: (2019-10-01)

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative
por: Laura Carbone, et al.
Publicado: (2020-10-01)

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: E E Gubar', et al.
Publicado: (2011-04-01)